Drug monopoly extension splits EU ministers in Biotech Act debate
EU health ministers split over a proposal to give certain innovative medicines an extra year of market protection, with EU Health Commissioner arguing the incentive is needed to keep biotech investment in Europe. Incoming Irish presidency, in the meantime, says it will work as quickly as possible.
Original Source
Read the full article at Euronews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.